🇺🇸 FDA
Patent

US 12121542

BCMA chimeric antigen receptor based on single domain antibody and use thereof

granted A61KA61K2239/46A61K35/17

Quick answer

US patent 12121542 (BCMA chimeric antigen receptor based on single domain antibody and use thereof) held by SHENZHEN PREGENE BIOPHARMA CO., LTD. expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SHENZHEN PREGENE BIOPHARMA CO., LTD.
Grant date
Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2239/46, A61K35/17, A61K40/11, A61K40/31